HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie M Cherrington Selected Research

Docetaxel (Taxotere)

7/2006SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity.
10/2003Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julie M Cherrington Research Topics

Disease

21Neoplasms (Cancer)
06/2015 - 01/2002
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2005 - 10/2002
2Neoplasm Metastasis (Metastasis)
07/2006 - 01/2003
2Breast Neoplasms (Breast Cancer)
10/2003 - 01/2003
2Carcinoma (Carcinomatosis)
08/2003 - 01/2002
1Type 2 Diabetes Mellitus (MODY)
08/2007
1Hematologic Neoplasms (Hematological Malignancy)
07/2004
1Inflammation (Inflammations)
11/2003
1Ascites
08/2003
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2003
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
05/2003
1Myeloproliferative Disorders (Myeloproliferative Disorder)
04/2003
1Diarrhea
04/2003
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
04/2003
1Headache (Headaches)
04/2003
1Abdominal Pain (Pain, Abdominal)
04/2003
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2003
1Fatigue
04/2003
1Pain (Aches)
04/2003
1Primary Myelofibrosis (Myelosclerosis)
04/2003
1Dyspnea (Shortness of Breath)
04/2003
1Colorectal Neoplasms (Colorectal Cancer)
02/2003
1Osteolysis
01/2003

Drug/Important Bio-Agent (IBA)

12Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2015 - 01/2002
11Sunitinib (Sutent)FDA Link
06/2015 - 01/2003
9Phosphotransferases (Kinase)IBA
07/2006 - 03/2002
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2006 - 01/2002
5Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2006 - 01/2002
5Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2006 - 01/2002
4Semaxinib (SU5416)IBA
07/2004 - 01/2002
4Tyrosine Kinase InhibitorsIBA
02/2004 - 01/2003
4orantinib (SU6668)IBA
08/2003 - 01/2002
3LigandsIBA
07/2006 - 07/2002
3tyrosine receptor (receptor, tyrosine)IBA
07/2006 - 07/2004
3Proteins (Proteins, Gene)FDA Link
07/2006 - 11/2003
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2006 - 08/2003
2Docetaxel (Taxotere)FDA Link
07/2006 - 10/2003
2fms-Like Tyrosine Kinase 3IBA
07/2006 - 10/2002
2Platelet-Derived Growth FactorIBA
05/2006 - 03/2002
2Imatinib Mesylate (Gleevec)FDA Link
05/2006 - 05/2003
2Biomarkers (Surrogate Marker)IBA
02/2004 - 02/2003
2toceranib phosphateIBA
11/2003 - 07/2003
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2003 - 05/2003
2Focal Adhesion Protein-Tyrosine KinasesIBA
11/2003 - 05/2003
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2003 - 01/2002
2OxindolesIBA
07/2003 - 05/2003
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2002 - 01/2002
1Dipeptidyl-Peptidase IV InhibitorsIBA
08/2007
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
07/2006
15- ((5- fluoro- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)methyl)- N- (2- hydroxy- 3- morpholin- 4- ylpropyl)- 2,4- dimethyl- 1H- pyrrole- 3- carboxamideIBA
07/2006
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
07/2006
13- (5- methyl- 2- (2- oxo- 1,2- dihydroindol- 3- ylidenemethyl)- 1H- pyrrol- 3- yl)propionic acidIBA
05/2006
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2004
1osteoblast cadherinIBA
02/2004
1Proto-Oncogene Proteins c-metIBA
11/2003
1Adenosine Triphosphate (ATP)IBA
11/2003
1Phospholipase C gammaIBA
11/2003
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2003
15- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
11/2003
1Fluorouracil (Carac)FDA LinkGeneric
10/2003
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2003
1Cytotoxins (Cytolysins)IBA
10/2003
1Paclitaxel (Taxol)FDA LinkGeneric
08/2003
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
08/2003
1Antineoplastic Agents (Antineoplastics)IBA
07/2003
1Cisplatin (Platino)FDA LinkGeneric
05/2003
1PlatinumIBA
05/2003
1AgarIBA
05/2003
1src-Family KinasesIBA
05/2003
1EpitopesIBA
05/2003
1Macrophage Colony-Stimulating FactorIBA
01/2003
1Tyrosine (L-Tyrosine)FDA Link
01/2003
1Dihydrotachysterol (AT 10)IBA
01/2003
1pyridinolineIBA
01/2003
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
03/2002

Therapy/Procedure

9Therapeutics
06/2015 - 01/2003
2Radiotherapy
03/2002 - 01/2002
1Drug Therapy (Chemotherapy)
05/2003
1Catheters
04/2003
1Injections
03/2002